Spheria Asset Management · 2026
Spheria argues that Ramsay Health Care's plan to spin off its 52.8% stake in Ramsay Santé moves $3bn of debt off its balance sheet and gives holders a cheap option on a French recovery, and that Healius's 24% fall overreacted to a result in which core pathology revenue grew 3.5% against flat industry volumes.
The Spheria Opportunities Fund returned -3.0% after fees in February 2026, 1.7 percentage points behind the S&P/ASX Mid-Small Accumulation Index. Australian small caps fell 2.6% while large caps rose 5.6% after higher inflation led to the first rate rise since 2023. Ramsay Health Care rose 18% on 1H26 revenue up 10% and a plan to distribute its 52.8% stake in Ramsay Santé to shareholders. Healius fell 24% although core pathology revenue grew 3.5% and it cut 400 staff. Spheria says it was wrong to hold little gold, expects AI agents to commoditise software more slowly than the market implies, and has bought Bapcor under new management.